Literature DB >> 7962969

Factors responsible for death in patients with pemphigus.

A J Kanwar1, S Dhar.   

Abstract

The records of 10 patients who died with pemphigus have been examined for factors affecting and contributing to death. Early initiation of therapy, the age at onset of the disease, and the mode of administration of corticosteroids, conventional or in pulse form, did not affect the survival. The cutaneous involvement was extensive in all 10 patients; it ranged between 30-80%. Septicemia was the commonest event preceding death; in 4 cases, it was due to Staphylococcus aureus.

Entities:  

Mesh:

Year:  1994        PMID: 7962969     DOI: 10.1111/j.1346-8138.1994.tb01811.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

Review 1.  Laryngeal pemphigus without skin manifestations and review of the literature.

Authors:  A Vasiliou; T P Nikolopoulos; L Manolopoulos; J Yiotakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-17       Impact factor: 2.503

2.  An unusual presentation of pemphigus vulgaris.

Authors:  Jesse P Houghton; Monica Ianosi-Irimie; Stacey B Trooskin; Hazar Michael
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-01

3.  The influence of corticosteroid treatment on the OPG/RANK/RANKL pathway and osteocalcin in patients with pemphigus.

Authors:  Marlena Chmielnicka; Anna Woźniacka; Jolanta D Torzecka
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

4.  The Prevalence of S. aureus Skin and Soft Tissue Infections in Patients with Pemphigus.

Authors:  Zeinab Fagheei Aghmiyuni; Ahmad Khorshidi; Rezvan Moniri; Tahereh Soori; Seyed Gholam Abbas Musavi
Journal:  Autoimmune Dis       Date:  2016-10-09

5.  Pemphigus vulgaris and infections: a retrospective study on 155 patients.

Authors:  Nafiseh Esmaili; Hossein Mortazavi; Pedram Noormohammadpour; Majid Boreiri; Tahereh Soori; Iman Vasheghani Farahani; Mitra Mohit
Journal:  Autoimmune Dis       Date:  2013-06-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.